These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 34825870)

  • 1. Roles of M
    Chen J; Zhang Q; Liu T; Tang H
    Curr Gene Ther; 2022; 22(1):40-50. PubMed ID: 34825870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA N6-methyladenosine methylation and skin diseases.
    Yu Y; Lu S; Jin H; Zhu H; Wei X; Zhou T; Zhao M
    Autoimmunity; 2023 Dec; 56(1):2167983. PubMed ID: 36708146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Progress of m
    Liu C; Wang X; Yang S; Cao S
    Biomed Res Int; 2023; 2023():3091204. PubMed ID: 37124930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions.
    Imam H; Kim GW; Siddiqui A
    Front Cell Infect Microbiol; 2020; 10():584283. PubMed ID: 33330128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The m6A methylation landscape stratifies hepatocellular carcinoma into 3 subtypes with distinct metabolic characteristics.
    Shen X; Hu B; Xu J; Qin W; Fu Y; Wang S; Dong Q; Qin L
    Cancer Biol Med; 2020 Nov; 17(4):937-952. PubMed ID: 33299645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
    Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
    J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation.
    Yue Y; Liu J; He C
    Genes Dev; 2015 Jul; 29(13):1343-55. PubMed ID: 26159994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer.
    Petri BJ; Klinge CM
    J Mol Endocrinol; 2023 Feb; 70(2):. PubMed ID: 36367225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of three m6A-related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma.
    Li Z; Li F; Peng Y; Fang J; Zhou J
    Cancer Med; 2020 Mar; 9(5):1877-1889. PubMed ID: 31943856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple m
    Qu N; Qin S; Zhang X; Bo X; Liu Z; Tan C; Wen G; Jiang H
    BMC Cancer; 2020 Feb; 20(1):165. PubMed ID: 32111180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of METTL3 and METTL14 in hepatocellular carcinoma.
    Liu X; Qin J; Gao T; Li C; Chen X; Zeng K; Xu M; He B; Pan B; Xu X; Pan Y; Sun H; Xu T; Wang S
    Aging (Albany NY); 2020 Nov; 12(21):21638-21659. PubMed ID: 33159022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of m6A modification in the biological functions and diseases.
    Jiang X; Liu B; Nie Z; Duan L; Xiong Q; Jin Z; Yang C; Chen Y
    Signal Transduct Target Ther; 2021 Feb; 6(1):74. PubMed ID: 33611339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The detection and functions of RNA modification m
    Zhang W; Qian Y; Jia G
    J Biol Chem; 2021 Aug; 297(2):100973. PubMed ID: 34280435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Roles of N
    Jiang T; Zhang X; Xu W
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 May; 55(3):527-534. PubMed ID: 38948273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-methyladenosine RNA methylation in liver diseases: from mechanism to treatment.
    Yang L; Tian S; Zheng X; Zhang M; Zhou X; Shang Y; Han Y
    J Gastroenterol; 2023 Aug; 58(8):718-733. PubMed ID: 37380929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma.
    Deng M; Fang L; Li SH; Zhao RC; Mei J; Zou JW; Wei W; Guo RP
    Mutagenesis; 2021 Oct; 36(5):369-379. PubMed ID: 34467992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma.
    Qin S; Mao Y; Chen X; Xiao J; Qin Y; Zhao L
    Int J Biol Sci; 2021; 17(12):3059-3079. PubMed ID: 34421350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comprehensive expression and functional analysis of m6A modification "readers" in hepatocellular carcinoma.
    Qin S; Liu G; Jin H; Chen X; He J; Xiao J; Qin Y; Mao Y; Zhao L
    Aging (Albany NY); 2022 Aug; 14(15):6269-6298. PubMed ID: 35963644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.